Related Experiment Videos
Telomerase and breast cancer
B S Herbert1, W E Wright, J W Shay
1Department of Cell Biology, The University of Texas Southwestern Medical Center at Dallas, Texas 75390-9039, USA.
Breast Cancer Research : BCR
|April 18, 2001
Summary
Telomerase is activated in most breast cancers but not normal tissues, making it a promising target. This study explores its use in breast cancer diagnostics and therapy development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Current breast cancer therapies face challenges with toxicity and drug resistance.
- Telomerase, an enzyme maintaining chromosome ends, is highly active in over 90% of breast carcinomas.
- This distinct expression pattern differentiates cancer cells from normal adjacent tissues.
Purpose of the Study:
- To investigate the role of telomerase in breast cancer diagnostics.
- To explore the potential of telomerase inhibitors for breast cancer treatment and prevention.
Main Methods:
- Analysis of telomerase expression in breast cancer pathology.
- Evaluation of telomerase inhibitors as therapeutic agents.
Main Results:
- Telomerase shows a distinct expression pattern in breast cancer, absent in normal tissues.
- This suggests telomerase as a viable target for diagnostic and therapeutic strategies.
Conclusions:
- Telomerase presents a significant opportunity for improving breast cancer diagnostics.
- Targeting telomerase offers a promising avenue for novel breast cancer treatments and prevention strategies.